Playback speed
10 seconds
Renal Denervation is Still Alive
0 views
September 14, 2018
Piedmont Heart interventional cardiologists discuss the latest outlook for using renal denervation to treat hypertension ...
read more ↘ at the Napa Valley Cardiology Conference. Dr. David Kandzari, just back from EuroPCR 2018 where he presented results from the SPYRAL HTN trial, talked about what has changed since an earlier trial of Medtronic’s Symplicity Renal Denervation System failed to meet its primary endpoint, and the current, more positive implications for patient care.
↖ read less
read more ↘ at the Napa Valley Cardiology Conference. Dr. David Kandzari, just back from EuroPCR 2018 where he presented results from the SPYRAL HTN trial, talked about what has changed since an earlier trial of Medtronic’s Symplicity Renal Denervation System failed to meet its primary endpoint, and the current, more positive implications for patient care.
↖ read less
Comments 0
Login to view comments.
Click here to Login